Genomic profiling to overcome resistance to molecularly targeted therapies in metastatic colorectal cancer
Publication
, Conference
Strickler, JH
Published in: CANCER SCIENCE
2023
Duke Scholars
Published In
CANCER SCIENCE
EISSN
1349-7006
ISSN
1347-9032
Publication Date
2023
Volume
114
Start / End Page
1522 / 1522
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1115 Pharmacology and Pharmaceutical Sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Strickler, J. H. (2023). Genomic profiling to overcome resistance to molecularly targeted therapies in metastatic colorectal cancer. In CANCER SCIENCE (Vol. 114, pp. 1522–1522).
Strickler, John H. “Genomic profiling to overcome resistance to molecularly targeted therapies in metastatic colorectal cancer.” In CANCER SCIENCE, 114:1522–1522, 2023.
Strickler JH. Genomic profiling to overcome resistance to molecularly targeted therapies in metastatic colorectal cancer. In: CANCER SCIENCE. 2023. p. 1522–1522.
Strickler, John H. “Genomic profiling to overcome resistance to molecularly targeted therapies in metastatic colorectal cancer.” CANCER SCIENCE, vol. 114, 2023, pp. 1522–1522.
Strickler JH. Genomic profiling to overcome resistance to molecularly targeted therapies in metastatic colorectal cancer. CANCER SCIENCE. 2023. p. 1522–1522.
Published In
CANCER SCIENCE
EISSN
1349-7006
ISSN
1347-9032
Publication Date
2023
Volume
114
Start / End Page
1522 / 1522
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1115 Pharmacology and Pharmaceutical Sciences
- 1112 Oncology and Carcinogenesis